Ulcerative colitis (UC) is a
chronic disease characterized by diffuse
inflammation of the intestinal mucosa of the large bowel. Omega-3 (ω3)
fatty acid supplementation has been associated with a decreased production of inflammatory
cytokines involved in UC pathogenesis. The aim of this study was to determine the preventive and therapeutic potential of
eicosapentaenoic acid monoglyceride (
MAG-EPA) in an in vivo rats model of UC induced by
dextran sulfate sodium (DSS). DSS rats were untreated or treated per os with
MAG-EPA. Morphological, histological, and biochemical analyses were performed following
MAG-EPA administrations. Morphological and histological analyses revealed that
MAG-EPA pretreatment (12 days pre-DSS) and treatment (6 days post-DSS) exhibited strong activity in reducing severity of disease in DSS rats. Following
MAG-EPA administrations, tissue levels of the proinflammatory
cytokines TNF-α, IL-1β, and
IL-6 were markedly lower compared with rats treated only with DSS.
MAG-EPA per os administration decrease neutrophil infiltration in colon tissues, as depicted by myelohyperoxidase activity. Results also revealed a reduced activation of NF-κB pathways correlated with a decreased expression of COX-2 in colon homogenates derived from
MAG-EPA-pretreated and treated rats. Tension measurements performed on colon tissues revealed that contractile responses to
methacholine and relaxing effect induced by
sodium nitroprusside were largely increased following
MAG-EPA treatment. The combined treatment of
MAG-EPA and
vitamin E displayed an antagonistic effect on anti-inflammatory properties of
MAG-EPA in DSS rats.